Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2001;54:539-542; doi:10.1136/jcp.54.7.539
Copyright © 2001 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
J Clin Pathol 2001; 54:539-542
© 2001 Journal of Clinical Pathology

p53 codon 72 polymorphism and human papillomavirus associated skin cancer

D P O'Connor1, E W Kay1, M Leader1, G J Atkins2, G M Murphy3 and M J E M F Mabruk1

1 Pathology Department, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland
2 Department of Microbiology, Moyne Institute of Preventive Medicine, Trinity College, Dublin 2, Ireland
3 Dermatology Department, Beaumont Hospital, Beaumont, Dublin 9, Ireland

Correspondence to:
Dr Mabruk, Pathology Department, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland mabruk{at}indigo.ie

Background/Aims—Non-melanoma skin cancers frequently harbour multiple human papillomavirus (HPV) types. A recent report suggests that a polymorphism of the p53 tumour suppressor gene that results in the substitution of a proline residue with an arginine residue at position 72 of the p53 protein might act as a risk factor in HPV associated malignancies. This study aimed to determine the following: (1) the relation between HPV infection and the development of cutaneous squamous cell carcinoma (SCC), and (2) whether there is a correlation between p53 codon 72 polymorphism and the development of SCC.

Methods—Blood samples were taken from 55 patients with skin cancer (both renal transplant recipients and immunocompetent patients with skin cancer) and 115 ethnically matched volunteers. A polymerase chain reaction based assay was used to determine p53 codon 72 genotypes. In addition, 49 benign and malignant lesions from 34 of the patients with skin cancer and 20 normal human skin samples from 20 of the control volunteers were examined for HPV.

Results—The proportions of p53 codon 72 genotypes found were 78% arginine homozygous, 2% proline homozygous, and 20% heterozygous among patients with skin cancer and 79% arginine homozygous, 3.5% proline homozygous, and 17.5% heterozygous among the control population. Statistical analysis showed no significant differences in the distribution of the two p53 isoforms between the patients with skin cancer and the control population. The predominant viral types detected in both the patients and the control group were EV associated HPVs, although the incidence was lower in normal skin samples than in malignant lesions or viral warts.

Conclusions—These results suggest that in a Celtic population there is no correlation between the presence of HPV, the p53 codon 72 arginine polymorphism, and the development of skin cancer.

Key Words: p53 codon 72 polymorphism • human papillomavirus • skin cancer


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Queille, S., Luron, L., Spatz, A., Avril, M. F., Ribrag, V., Duvillard, P., Hiesse, C., Sarasin, A., Armand, J. P., Daya-Grosjean, L. (2007). Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene. Carcinogenesis 28: 724-731 [Abstract] [Full Text]  
  • Pfister, H. (2003). Chapter 8: Human Papillomavirus and Skin Cancer. J Natl Cancer Inst Monogr 2003: 52-56 [Abstract] [Full Text]  
  • van Diest, P J, Holzel, H (2002). Cervical cancer. J. Clin. Pathol. 55: 241-242 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs